These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease. Pang CP, Zhang J, Woo J, Chan D, Law LK, Tong SF, Kwok T, Kay R. Mov Disord; 1998 May; 13(3):529-32. PubMed ID: 9613747 [Abstract] [Full Text] [Related]
3. [Genetic polymorphisms of cytochrome P450 1A1 and susceptibility of early-onset Parkinson's disease]. Liu P, Liu Z, Shao M, Chen B. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):283-5. PubMed ID: 11484167 [Abstract] [Full Text] [Related]
4. Mutation frequencies of the cytochrome CYP2D6 gene in Parkinson disease patients and in families. Lucotte G, Turpin JC, Gérard N, Panserat S, Krishnamoorthy R. Am J Med Genet; 1996 Jul 26; 67(4):361-5. PubMed ID: 8837703 [Abstract] [Full Text] [Related]
5. [The alpha-synuclein gene microsatellite polymorphism and late-onset sporadic Parkinson's disease susceptibility]. Zhao XP, Zheng HM, Xie HJ, Ding SJ, Ren DM. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug 26; 21(4):339-41. PubMed ID: 15300629 [Abstract] [Full Text] [Related]
6. Association between the oxidative polymorphism and early onset of Parkinson's disease. Agúndez JA, Jiménez-Jiménez FJ, Luengo A, Bernal ML, Molina JA, Ayuso L, Vázquez A, Parra J, Duarte J, Coria F. Clin Pharmacol Ther; 1995 Mar 26; 57(3):291-8. PubMed ID: 7697946 [Abstract] [Full Text] [Related]
7. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Kurth MC, Kurth JH. Am J Med Genet; 1993 Oct 15; 48(3):166-8. PubMed ID: 8291573 [Abstract] [Full Text] [Related]
8. CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Elbaz A, Levecque C, Clavel J, Vidal JS, Richard F, Amouyel P, Alpérovitch A, Chartier-Harlin MC, Tzourio C. Ann Neurol; 2004 Mar 15; 55(3):430-4. PubMed ID: 14991823 [Abstract] [Full Text] [Related]
9. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of Parkinson's disease: a meta-analysis. Christensen PM, Gøtzsche PC, Brøsen K. Pharmacogenetics; 1998 Dec 15; 8(6):473-9. PubMed ID: 9918130 [Abstract] [Full Text] [Related]
10. [Association between cytochrome P-450 enzyme gene polymorphisms and Parkinson's disease]. Wang J, Liu Z, Chen B. Zhonghua Yi Xue Za Zhi; 2000 Aug 15; 80(8):585-7. PubMed ID: 11798822 [Abstract] [Full Text] [Related]
11. CYP2D6-debrisoquine hydroxylase gene polymorphism in multiple system atrophy. Planté-Bordeneuve V, Bandmann O, Wenning G, Quinn NP, Daniel SE, Harding AE. Mov Disord; 1995 May 15; 10(3):277-8. PubMed ID: 7651442 [Abstract] [Full Text] [Related]
12. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease]. Wang J, Liu Z, Chen B. Zhonghua Yi Xue Za Zhi; 2000 May 15; 80(5):346-8. PubMed ID: 11798784 [Abstract] [Full Text] [Related]
20. Examination of the MSX1 gene in patients with Parkinson's disease. Deng H, Zhu SH, Le WD, Yang HR, Lv HW, Xu HB, Xie WJ, Jankovic J. Acta Neurol Scand; 2009 Dec 15; 120(6):442-4. PubMed ID: 19922584 [Abstract] [Full Text] [Related] Page: [Next] [New Search]